-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.50978.43% Upside
Sensei Biotherapeutics, Inc. Frequently Asked Questions
-
What analysts cover Sensei Biotherapeutics, Inc.?
Sensei Biotherapeutics, Inc. has been rated by research analysts at Stephens, Citigroup in the past 90 days.